Sapporo-Kosei General Hospital

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• Colorectal cancer2 trials
• Crohn's disease2 trials
• Liver cirrhosis2 trials
• Ulcerative colitis2 trials
• High blood pressure1 trial
• Liver and biliary tract cancer1 trial
• Melanoma1 trial

Phase

• Phase 35 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Completed3 trials
• Recruiting3 trials
• Active, not recruiting2 trials

Lead sponsor

• Boehringer Ingelheim2 trials
• Takeda2 trials
• Eisai Inc.1 trial
• Gilead Sciences1 trial
• National Cancer Center Hospital East1 trial
• and 1 more

Running trials

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)

  NCT05326230· Otsuka Medical Devices Co., Ltd. Japan· Source

• Active, not recruiting

  A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

  NCT04738942· Phase 3· Takeda· Source

• Recruiting

  Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

  NCT04288999· Phase 3· National Cancer Center Hospital East· Source

  Contact: Hideki Yamagami

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Colorectal cancer1 recruiting
• Liver cirrhosis1 recruiting

Closed trials

• Completed

  A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

  NCT05091346· Phase 1/2· Eisai Inc.· Source

• Completed

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· Phase 2· Gilead Sciences· Source

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source